Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
A special investigation by the Manchester Evening New's Nicole Wootton-Cane has revealed the Ozempic and Wegovy sold on the ...